Skip to content

To compare the effects of sufentanil and oxalidine on improving postoperative analgesia and postoperative cognitive dysfunction

To compare the effects of sufentanil and oxalidine on improving postoperative analgesia and postoperative cognitive dysfunction

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090887
Enrollment
Unknown
Registered
2024-10-15
Start date
2024-10-20
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative cognitive dysfunction

Interventions

Sufentanil group:Induction of anesthesia: Sufentanil group: intravenous injection of propofol 1-1.5 mg/kg, sufentanil 0.3ug/kg, when the patient lost consciousness, cisatracurium 0.2 mg/kg, until a sa
The Oxalidine group:Induction of anesthesia: The patients in the oxalidine group received intravenous injection of propofol 1-1.5 mg/kg and oxalidine 60 ug/kg, and cisatracurium 0.2 mg/kg was given wh

Sponsors

Hospital of Traditional Chinese Medicine Affiliated to Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) undergoing elective lower limb long bone surgery (the operation time was 3-4 hours); (2) age =65 years old; (3) ASA?/?, MMSE score =23; (4) those who voluntarily participated in the study and signed the informed consent form

Exclusion criteria

Exclusion criteria: (1) known to be allergic to the components of the investigational drug; (2) inability to cooperate, such as mental disorders or anticipated difficulties with neuropsychological assessment, communication difficulties related to pronunciation or dialect. (3) those with a history of alcohol or drug abuse; (4) participants who were enrolled in or had enrolled in another clinical trial within 12 weeks before the trial; (5) Other patients who, in the judgment of the investigator, would not be eligible to participate in the trial, such as acute or chronic infectious diseases, secondary surgery, ASA score greater than grade III, illiteration, stroke or transient ischemic attack within 1 month.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative cognitive impairment;

Secondary

MeasureTime frame
The use of analgesic drugs in patients;Patient's pain level;The mean arterial pressure of the patients during the procedure;Adverse reactions within 24 hours after operation were recorded;Length OF STAY;Continuous pulse oxygen saturation was measured 24 hours after surgery;The first postoperative defecation time;The first time of ground movement;

Countries

China

Contacts

Public ContactPeimin Lin

Hospital of Traditional Chinese Medicine Affiliated to Southwest Medical University

284238497@qq.com+86 139 8245 2939

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026